AR016006A1 - Compuestos condensados con anillo de 5 miembros, sustituidos con sulfonamida, su utilizacion como medicamentos, asi como preparados farmaceuticosque los contienen. - Google Patents
Compuestos condensados con anillo de 5 miembros, sustituidos con sulfonamida, su utilizacion como medicamentos, asi como preparados farmaceuticosque los contienen.Info
- Publication number
- AR016006A1 AR016006A1 ARP980105628A ARP980105628A AR016006A1 AR 016006 A1 AR016006 A1 AR 016006A1 AR P980105628 A ARP980105628 A AR P980105628A AR P980105628 A ARP980105628 A AR P980105628A AR 016006 A1 AR016006 A1 AR 016006A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- alkyl
- replaced
- methyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos condensados con un anillo de 5 miembros, sustituidos con sulfonamida de la formula (I), en la que significan: R1 y R2, independientemente uno deotro, son hidrogeno, CF3, alquilo con C1-6; o R2 y R9 son en comun un enlace; o R2 es -OR10a, cuando X significa -CR22R23-; R10a es hidrogeno, acetiloo alquilo C1-3; R3 es R10b-CnH2n-NR11- o R10b-CnH2n-, pudiendo un grupo CH2 en los grupos CnH2n estar reemplazado por -O-, -CO-, -S-, -SO-, -SO2- o -NR12a-;R12a es hidrogeno, metilo o etilo; R10b es metilo, cicloalquilo C3-8, CF3, C2F5 o C3F7; n es 0 - 10; R11 es hidrogeno o alquilo C1-6; o R10b y R11 son, enen comun, un enlace, siempre y cuando que n sea mayor que 2; R3 es en comun con R4 una cadena de alquileno C3-8, pudiendo un grupo CH2de la cadena dealquileno estar reemplazado por -O-, -CO-, -S-, -SO-, -SO2- o -NR12a-; R12a es hidrogeno, metilo o etilo; R4 es R13 -CrH2r, pudiendo un grupo CH2 del grupoCrH2r estar reemplazado por -O-, -CH=CH-, -C:::C-, -CO-, -CO-O-, -O-CO-, -S-, -SO-, -SO2-, -NR14- o -CONR14-; R14 es hidrogeno, alquilo C1-3, -CyH2y-OR12b,-CyH2y-NR12b2; R12b es hidrogeno, metilo o etilo; y es 2 o 3; R13 es CH3, C2F5, C3F7, cicloalquilo C3-7, -NR15R16, -CONR15R16, -OR17, -COOR17, fenilo o unheterociclo que contiene N con C1-9; estando el fenilo y el heterociclo que contiene N sin sustituir o sustituidos con 1 o 2 sustituyentes, seleccionados entreel grupo que consta de F, Cl, Br, I, CF3, NO2, CN, NH2, OH, metilo, etilo, metoxi, dimetilamino, sulfamoílo, metilsulfonilo y metilsulfonilamino; R15 y R16son, independientemente uno de otro, hidrogeno o alquilo C1-4; o R15 y R16, son en comun, una cadena de 4 o 5 grupos de metileno, de los cuales un grupo CH2puede estar reemplazado por -O-, -S-, -NH-, -N(CH3)- o -N(bencilo)-; R17 es hidrogeno, alquilo C1-3, -CzH2zOR12c; R12c es hidrogeno, metilo o etilo; z es 2 o3; r es 0 - 20; R5, R6, R7 y R8, independientemente unos de otros, son hidrogeno, F, Cl, Br, I, alquilo C1-5, cicloalquilo C3-8, -CN, -CF3, C2F5, -C3F7, -N3,-NO2, -Y-CsH2s-R18, fenilo, tienilo, furilo o un heterociclo que contiene N con C1-9, pudiendo los fenilo, tienilo, furilo y el heterociclo que contiene N
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19749453A DE19749453A1 (de) | 1997-11-10 | 1997-11-10 | Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016006A1 true AR016006A1 (es) | 2001-05-30 |
Family
ID=7848065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105628A AR016006A1 (es) | 1997-11-10 | 1998-11-06 | Compuestos condensados con anillo de 5 miembros, sustituidos con sulfonamida, su utilizacion como medicamentos, asi como preparados farmaceuticosque los contienen. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6015822A (es) |
| EP (1) | EP0915087B1 (es) |
| JP (1) | JP4331809B2 (es) |
| KR (1) | KR19990045147A (es) |
| CN (1) | CN1219533A (es) |
| AR (1) | AR016006A1 (es) |
| AT (1) | ATE236120T1 (es) |
| AU (1) | AU742199B2 (es) |
| BR (1) | BR9804995A (es) |
| CA (1) | CA2253211C (es) |
| CZ (1) | CZ363798A3 (es) |
| DE (2) | DE19749453A1 (es) |
| DK (1) | DK0915087T3 (es) |
| ES (1) | ES2196456T3 (es) |
| HR (1) | HRP980585B1 (es) |
| HU (1) | HUP9802590A3 (es) |
| ID (1) | ID21282A (es) |
| IL (1) | IL126955A (es) |
| MY (1) | MY115619A (es) |
| NO (1) | NO312546B1 (es) |
| NZ (1) | NZ332633A (es) |
| PL (1) | PL329596A1 (es) |
| PT (1) | PT915087E (es) |
| RU (1) | RU2223951C2 (es) |
| SI (1) | SI0915087T1 (es) |
| SK (1) | SK283866B6 (es) |
| TR (1) | TR199802270A2 (es) |
| TW (1) | TW427970B (es) |
| ZA (1) | ZA9810202B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1332943C (zh) | 1998-07-08 | 2007-08-22 | 萨诺费－阿文蒂斯德国有限公司 | 硫取代的磺酰基氨基羧酸n－芳基酰胺,其制备方法、用途以及含有该化合物的药物制剂 |
| DE19929076A1 (de) * | 1999-06-25 | 2000-12-28 | Aventis Pharma Gmbh | Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| EP1240147A1 (en) | 1999-12-21 | 2002-09-18 | Icagen, Inc. | Potassium channel inhibitors |
| US6849634B2 (en) | 2000-12-21 | 2005-02-01 | Icagen | Potassium channel inhibitors |
| WO2003053954A1 (en) * | 2001-12-12 | 2003-07-03 | F. Hoffmann-La Roche Ag | Benzothiophenes as adenosine receptor modulators |
| US7119112B2 (en) * | 2002-02-28 | 2006-10-10 | Icagen, Inc. | Sulfonamides as potassium channel blockers |
| KR101126895B1 (ko) * | 2006-01-24 | 2012-03-20 | 일라이 릴리 앤드 캄파니 | 프로게스테론 수용체의 인돌 술폰아미드 조절제 |
| JP2009026126A (ja) * | 2007-07-20 | 2009-02-05 | Nec Electronics Corp | 半導体装置 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR910003337B1 (ko) * | 1983-03-04 | 1991-05-27 | 오오쓰까세이야꾸 가부시끼가이샤 | 인단 유도체 및 그 염의 제조방법 |
| DE3623944A1 (de) * | 1986-07-16 | 1988-02-11 | Thomae Gmbh Dr K | Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
| US5877218A (en) * | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
-
1997
- 1997-11-10 DE DE19749453A patent/DE19749453A1/de not_active Withdrawn
-
1998
- 1998-11-04 PT PT98120913T patent/PT915087E/pt unknown
- 1998-11-04 AT AT98120913T patent/ATE236120T1/de not_active IP Right Cessation
- 1998-11-04 EP EP98120913A patent/EP0915087B1/de not_active Expired - Lifetime
- 1998-11-04 DE DE59807718T patent/DE59807718D1/de not_active Expired - Lifetime
- 1998-11-04 DK DK98120913T patent/DK0915087T3/da active
- 1998-11-04 ES ES98120913T patent/ES2196456T3/es not_active Expired - Lifetime
- 1998-11-04 SI SI9830428T patent/SI0915087T1/xx unknown
- 1998-11-05 NO NO19985171A patent/NO312546B1/no unknown
- 1998-11-06 AR ARP980105628A patent/AR016006A1/es not_active Application Discontinuation
- 1998-11-06 ID IDP981460A patent/ID21282A/id unknown
- 1998-11-06 RU RU98120643/04A patent/RU2223951C2/ru not_active IP Right Cessation
- 1998-11-06 AU AU91398/98A patent/AU742199B2/en not_active Ceased
- 1998-11-06 NZ NZ332633A patent/NZ332633A/xx unknown
- 1998-11-06 TW TW087118463A patent/TW427970B/zh active
- 1998-11-08 IL IL12695598A patent/IL126955A/en active IP Right Grant
- 1998-11-09 SK SK1545-98A patent/SK283866B6/sk unknown
- 1998-11-09 PL PL98329596A patent/PL329596A1/xx unknown
- 1998-11-09 US US09/188,181 patent/US6015822A/en not_active Expired - Lifetime
- 1998-11-09 TR TR1998/02270A patent/TR199802270A2/xx unknown
- 1998-11-09 JP JP31779998A patent/JP4331809B2/ja not_active Expired - Fee Related
- 1998-11-09 ZA ZA9810202A patent/ZA9810202B/xx unknown
- 1998-11-09 HU HU9802590A patent/HUP9802590A3/hu unknown
- 1998-11-09 HR HR980585A patent/HRP980585B1/xx not_active IP Right Cessation
- 1998-11-09 CZ CZ983637A patent/CZ363798A3/cs unknown
- 1998-11-10 CA CA002253211A patent/CA2253211C/en not_active Expired - Fee Related
- 1998-11-10 KR KR1019980047928A patent/KR19990045147A/ko not_active Application Discontinuation
- 1998-11-10 CN CN98124145A patent/CN1219533A/zh active Pending
- 1998-11-10 BR BR9804995-0A patent/BR9804995A/pt not_active IP Right Cessation
- 1998-11-10 MY MYPI98005112A patent/MY115619A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR014448A1 (es) | Compuesto de alanina, una composicion farmaceutica, uso del compuesto y proceso para la preparacion del compuesto | |
| ATE270103T1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
| AR032781A1 (es) | Amidas ariladas de acidos furan- y tiofencarboxilicos, composiciones farmaceuticas, su utilizacion para la preparacion de medicamento como tambien las composiciones farmaceuticas que las contienen | |
| AR031531A1 (es) | Derivados de las sulfonamidas que poseen actividad modulatoria e inhibitoria de las jun-quinasas (jnk), uso de dichos derivados en la preparacion de composiciones para dichos tratamientos y composiciones farmaceuticas formuladas con dichos derivados. | |
| FR2658511B1 (fr) | Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant. | |
| WO2003016291A1 (fr) | Activateur du recepteur $g(d) sensible au proliferateur de peroxysome | |
| ECSP034730A (es) | Quinazolinas como inhibidores de mmp-13 | |
| AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
| AR057894A1 (es) | Derivados de tiofeno | |
| RU2017108785A (ru) | Пестицидные композиции и связанные с ними способы | |
| CO5090848A1 (es) | Compuestos de benceno sustituidos, procedimientos para su preparacion, y composiciones herbicidas y de foliantes que los contienen | |
| AR016006A1 (es) | Compuestos condensados con anillo de 5 miembros, sustituidos con sulfonamida, su utilizacion como medicamentos, asi como preparados farmaceuticosque los contienen. | |
| HRP20090264T1 (en) | Phenyl-piperazin methanone derivatives | |
| RU2010116253A (ru) | Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила | |
| CA2335477A1 (en) | Sulfonamide inhibitors of aspartyl protease | |
| CO5640098A2 (es) | Acidos biariloximetilaren-carboxilicos | |
| RU2007101685A (ru) | Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения | |
| BR0309447A (pt) | Composto, agente, processos para a preparação dos mesmos, e para o combate do crescimento de plantas indesejadas, e, uso do composto | |
| RU2003120080A (ru) | Орто-замещенные азотсодержащие бисарильные соединения для применения в качестве ингибиторов калиевого канала, а также содержащие их фармацевтические композиции | |
| SE0201937D0 (sv) | Therapeutic agents | |
| FI952709A0 (fi) | 1,4-bentsodiatsepiinijohdannaisia ja niiden käyttö cck-modulaattoreina | |
| AR039562A1 (es) | Compuestos oxo-azabiciclicos | |
| ECSP045420A (es) | Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos | |
| AR039190A1 (es) | Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto | |
| AR031857A1 (es) | Pirroloquinolonas, composiciones farmaceuticas, uso de las mismas para preparar un medicamento antiviral y un metodo para producir un intermediario |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |